Sargent Bickham Lagudis’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $417K | Hold |
3,274
| – | – | 0.03% | 203 |
|
|
2022
Q3 | $343K | Buy |
3,274
+26
| +0.8% | +$2.72K | 0.03% | 201 |
|
|
2022
Q2 | $341K | Buy |
3,248
+24
| +0.7% | +$2.52K | 0.03% | 212 |
|
|
2022
Q1 | $412K | Sell |
3,224
-97
| -3% | -$12.4K | 0.03% | 196 |
|
|
2021
Q4 | $410K | Buy |
3,321
+1
| +0% | +$123 | 0.03% | 186 |
|
|
2021
Q3 | $472K | Hold |
3,320
| – | – | 0.04% | 174 |
|
|
2021
Q2 | $518K | Hold |
3,320
| – | – | 0.04% | 167 |
|
|
2021
Q1 | $516K | Hold |
3,320
| – | – | 0.05% | 158 |
|
|
2020
Q4 | $497K | Buy |
3,320
+165
| +5% | +$24.7K | 0.05% | 162 |
|
|
2020
Q3 | $417K | Hold |
3,155
| – | – | 0.04% | 156 |
|
|
2020
Q2 | $366K | Sell |
3,155
-25
| -0.8% | -$2.9K | 0.04% | 157 |
|
|
2020
Q1 | $312K | Buy |
3,180
+26
| +0.8% | +$2.55K | 0.04% | 167 |
|
|
2019
Q4 | $458K | Hold |
3,154
| – | – | 0.05% | 150 |
|
|
2019
Q3 | $420K | Hold |
3,154
| – | – | 0.05% | 143 |
|
|
2019
Q2 | $360K | Hold |
3,154
| – | – | 0.04% | 159 |
|
|
2019
Q1 | $391K | Buy |
3,154
+1
| +0% | +$124 | 0.05% | 162 |
|
|
2018
Q4 | $318K | Hold |
3,153
| – | – | 0.04% | 166 |
|
|
2018
Q3 | $402K | Hold |
3,153
| – | – | 0.05% | 151 |
|
|
2018
Q2 | $341K | Hold |
3,153
| – | – | 0.04% | 155 |
|
|
2018
Q1 | $334K | Hold |
3,153
| – | – | 0.04% | 157 |
|
|
2017
Q4 | $369K | Sell |
3,153
-308
| -9% | -$36K | 0.04% | 158 |
|
|
2017
Q3 | $393K | Buy |
3,461
+309
| +10% | +$35.1K | 0.05% | 156 |
|
|
2017
Q2 | $393K | Hold |
3,152
| – | – | 0.05% | 154 |
|
|
2017
Q1 | $374K | Hold |
3,152
| – | – | 0.05% | 158 |
|
|
2016
Q4 | $316K | Hold |
3,152
| – | – | 0.05% | 157 |
|
|
2016
Q3 | $398 | Sell |
3,152
-771
| -20% | -$97 | 0.06% | 148 |
|
|
2016
Q2 | $459K | Hold |
3,923
| – | – | 0.07% | 140 |
|
|
2016
Q1 | $406K | Buy |
+3,923
| New | +$406K | 0.07% | 146 |
|